Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James McIntyre

Showing results (81-90 of 104) with videos related to

Pageof 11
Sort By:
AIDS (London, England)|February 5, 2011
First-line antiretroviral therapy after single-dose nevirapine exposure in South Africa: a cost-effectiveness analysis of the OCTANE trialAndrea L Ciaranello, Shahin Lockman, Kenneth A Freedberg, et al.
Plos Medicine|November 24, 2011
Optimal uses of antiretrovirals for prevention in HIV-1 serodiscordant heterosexual couples in South Africa: a modelling studyTimothy B Hallett, Jared M Baeten, Renee Heffron, et al.
Antimicrobial Agents and Chemotherapy|October 20, 2010
Population pharmacokinetics of nevirapine in HIV-1-infected pregnant women and their neonatesSihem Benaboud, Didier K Ekouévi, Saik Urien, et al.
Antimicrobial Agents and Chemotherapy|December 24, 2008
Population pharmacokinetics of emtricitabine in human immunodeficiency virus type 1-infected pregnant women and their neonatesDéborah Hirt, Saik Urien, Elisabeth Rey, et al.
Nature Communications|January 26, 2019
A child with perinatal HIV infection and long-term sustained virological control following antiretroviral treatment cessationAvy Violari, Mark F Cotton, Louise Kuhn, et al.
Antimicrobial Agents and Chemotherapy|April 6, 2011
Plasma and intracellular tenofovir pharmacokinetics in the neonate (ANRS 12109 trial, step 2)Déborah Hirt, Didier K Ekouévi, Alain Pruvost, et al.
Lancet (London, England)|July 17, 2007
Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: a randomised controlled trialNancy S Padian, Ariane van der Straten, Gita Ramjee, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 18, 2011
Role of low-frequency HIV-1 variants in failure of nevirapine-containing antiviral therapy in women previously exposed to single-dose nevirapineValerie F Boltz, Yu Zheng, Shahin Lockman, et al.
AIDS (London, England)|March 25, 2009
Tolerance and viral resistance after single-dose nevirapine with tenofovir and emtricitabine to prevent vertical transmission of HIV-1, Elise Arrivé, Marie-Laure Chaix, et al.
Journal of Virology|March 16, 2004
Hierarchical targeting of subtype C human immunodeficiency virus type 1 proteins by CD8+ T cells: correlation with viral loadAgatha Masemola, Tumelo Mashishi, Greg Khoury, et al.
Pageof 11

Showing results (81-90 of 104) with videos related to

Sort By:
Pageof 11
AIDS (London, England)|February 5, 2011
First-line antiretroviral therapy after single-dose nevirapine exposure in South Africa: a cost-effectiveness analysis of the OCTANE trialAndrea L Ciaranello, Shahin Lockman, Kenneth A Freedberg, et al.
Plos Medicine|November 24, 2011
Optimal uses of antiretrovirals for prevention in HIV-1 serodiscordant heterosexual couples in South Africa: a modelling studyTimothy B Hallett, Jared M Baeten, Renee Heffron, et al.
Antimicrobial Agents and Chemotherapy|October 20, 2010
Population pharmacokinetics of nevirapine in HIV-1-infected pregnant women and their neonatesSihem Benaboud, Didier K Ekouévi, Saik Urien, et al.
Antimicrobial Agents and Chemotherapy|December 24, 2008
Population pharmacokinetics of emtricitabine in human immunodeficiency virus type 1-infected pregnant women and their neonatesDéborah Hirt, Saik Urien, Elisabeth Rey, et al.
Nature Communications|January 26, 2019
A child with perinatal HIV infection and long-term sustained virological control following antiretroviral treatment cessationAvy Violari, Mark F Cotton, Louise Kuhn, et al.
Antimicrobial Agents and Chemotherapy|April 6, 2011
Plasma and intracellular tenofovir pharmacokinetics in the neonate (ANRS 12109 trial, step 2)Déborah Hirt, Didier K Ekouévi, Alain Pruvost, et al.
Lancet (London, England)|July 17, 2007
Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: a randomised controlled trialNancy S Padian, Ariane van der Straten, Gita Ramjee, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 18, 2011
Role of low-frequency HIV-1 variants in failure of nevirapine-containing antiviral therapy in women previously exposed to single-dose nevirapineValerie F Boltz, Yu Zheng, Shahin Lockman, et al.
AIDS (London, England)|March 25, 2009
Tolerance and viral resistance after single-dose nevirapine with tenofovir and emtricitabine to prevent vertical transmission of HIV-1, Elise Arrivé, Marie-Laure Chaix, et al.
Journal of Virology|March 16, 2004
Hierarchical targeting of subtype C human immunodeficiency virus type 1 proteins by CD8+ T cells: correlation with viral loadAgatha Masemola, Tumelo Mashishi, Greg Khoury, et al.
Pageof 11